I think that he has reduced - the shares were in his own name - the franking credits would not be very efficient in that instance.
ACW This biotech stock raised $11M in a risk-off environment. Its Alzheimer's drug could change the game
History-making uranium sample grades and an imminent drill run. Infini Resources is poised to transform in 2025